Showing 1,098 results

Filters Content type: News, Editors' picks, About HIV Topic: Hepatitis C treatment

Direct-acting antiviral medicines interfere with different steps of the hepatitis C lifecycle. A combination of drugs may be co-formulated into a single pill. Modern treatment typically lasts for two or three months, usually does not cause side-effects and cures more than 95% of treated people.

Experiences of stigma

Hep C stigma as a pharmaceutical marketing device

Editor's pick
Bad Blood (blog)
27 July 2013
Hepatitis C treatment

The time bomb is ticking….Defuse hepatitis C, the viral time bomb!

Editor's pick
HepCoalition
25 July 2013
Hepatitis C treatment

Combining treatments for people who inject drugs is the first step towards eliminating hepatitis C

Editor's pick
Medical Xpress
25 July 2013
Hepatitis C treatment

Hepatitis treatment debuts on WHO Model Essential Medicines List

Editor's pick
World Health Organization (press release)
25 July 2013
Hepatitis C transmission & prevention

Number of patients diagnosed with HCV in England increased by a third between 2010 and 2012

News
25 July 2013
New & experimental hepatitis C treatment

Are Patients Receiving the Latest Anti-HCV Drugs?

Editor's pick
AGA Journals blog
22 July 2013
Hepatitis C treatment

HIV/HCV co-infected people can do well on hepatitis C triple therapy despite contraindications

News
22 July 2013
New & experimental hepatitis C treatment

How to Save $200 Billion and Cure Hepatitis C

Editor's pick
Xconomy
22 July 2013
Hepatitis C treatment

NICE draft guidance recommends drugs to treat chronic hepatitis C in children and young people

Editor's pick
NICE
19 July 2013
Treatment outcomes & life expectancy

Poor treatment outcomes common among children with HIV/HCV coinfection

Editor's pick
Healio.com
9 July 2013
Hepatitis C treatment side-effects

Fear of future health problems encourage people to start and complete HCV therapy but concern about side-effects is a deterrent

News
28 June 2013
New & experimental hepatitis C treatment

The beginning of the end of hepatitis C?

News
25 June 2013
Hepatitis C treatment

INCIVO® (telaprevir) Receives European Commission Approval for Twice Daily Dosing for Treatment of Genotype-1 Chronic Hepatitis C Virus (HCV)

Editor's pick
PR Newswire
31 May 2013
Hepatitis C treatment

Hepatitis C treatment gap in Europe: France doing well but Italy treated fewer than one in a hundred patients in 2010

News
28 May 2013
Hepatitis C treatment

Recent Advances in the Treatment of Chronic Hepatitis C Threaten to Leave Some Parts of the World Behind

Editor's pick
Medscape (requires registration)
21 May 2013
Hepatitis C treatment

Triple therapy for hepatitis C is effective after liver transplantation, but side-effects are common

News
16 May 2013
Hepatitis C treatment

Movement for global access to hepatitis C treatment building momentum

News
9 May 2013
Hepatitis C treatment

Report highlights major failings in UK response to hepatitis C

News
7 May 2013
New & experimental hepatitis C treatment

Combination Drugs are the Future of the European Hepatitis B and C Therapeutics Markets

Editor's pick
PR Newswire
1 May 2013
Hepatitis C treatment

Triple-drug HCV therapy comes with high risk of serious adverse events for people with cirrhosis

News
30 April 2013
Hepatitis C treatment

Hepatitis C Viral Load Fluctuates Without Treatment

Editor's pick
Medscape (requires registration)
5 April 2013
Hepatitis C treatment

Integrated Psych Care for High-Risk Hep C Patients May Increase Antiviral Treatment

Editor's pick
Medscape (requires registration)
27 March 2013
Hepatitis C treatment

Once-Daily Ribavirin Promising for Hepatitis C

Editor's pick
Medscape (requires registration)
27 March 2013
Hepatitis C treatment

Pakistan: Hepatitis C treatment: Expatriate scientists weigh in on interferon issue

Editor's pick
The Express Tribune
26 March 2013